Duration of antiplatelet therapy after complex PCI in the TWILIGHT-COMPLEX trial: The Goldilocks dilemma

Carlos G. Santos-Gallego, Juan Badimon

Research output: Contribution to journalComment/debate

7 Scopus citations
Original languageEnglish
Pages (from-to)e93-e95
JournalCardiovascular Research
Volume116
Issue number8
DOIs
StatePublished - 1 Jul 2020

Keywords

  • Antiplatelet therapy
  • Atherosclerosis
  • Bleeding
  • Complex percutaneous coronary intervention
  • Ticagrelor

Cite this